Alnylam Pharmaceuticals EPS beats by $0.33, beats on revenue

|About: Alnylam Pharmaceuticals, Inc. (ALNY)|By:, SA News Editor

Alnylam Pharmaceuticals (NASDAQ:ALNY): Q2 Non-GAAP EPS of -$1.83 beats by $0.33; GAAP EPS of -$2.02 beats by $0.14.

Revenue of $44.71M (+49.5% Y/Y) beats by $2.47M.

Press Release

Subscribe for full text news in your inbox